Text and Data Mining valid from 2015-02-26
Received: 30 June 2014
Revised: 6 October 2014
Accepted: 1 December 2014
First Online: 26 February 2015
: Pieter E. Postmus has board membership at Boehringer Ingelheim (advisory board on nintedanib), payment for lectures BMS (chair and lecture at symposium at WCLC 2013). The remaining authors declare no conflict of interest.